Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2006-1-6
pubmed:abstractText
The human gene Hugl-1 (Llgl/Lgl1) has significant homology to the Drosophila tumor suppressor gene lethal(2)giant larvae (lgl). The lgl gene codes for a cortical cytoskeleton protein, Lgl, that is involved in maintaining cell polarity and epithelial integrity. We speculate that Hugl-1 might play a role in epithelial-mesenchymal transition (EMT) and that loss of Hugl-1 expression plays a role in the development or progression of malignant melanoma. Thus, we evaluated melanoma cell lines and tissue samples of malignant melanoma for loss of Hugl-1 transcription. We found that Hugl-1 was downregulated or lost in all cell lines and in most of the tumor samples analysed, and that these losses were associated with advanced stage of the disease. Reduced Hugl-1 expression occurred as early as in primary tumors detected by both immunohistochemical and reverse transcription-polymerase chain reaction (RT-PCR) analysis. Functional assays with stable Hugl-1-transfected cell lines revealed that Hugl-1 expression increased cell adhesion and decreased cell migration. Further, downregulation of MMP2 and MMP14 (MT1-MMP) and re-expression of E-cadherin was found in the Hugl-1-expressing cell clones supporting a role of Hugl-1 in EMT. Our studies thus indicate that loss of Hugl-1 expression contributes to melanoma progression.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0950-9232
pubmed:author
pubmed:issnType
Print
pubmed:day
5
pubmed:volume
25
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
103-10
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:16170365-Blotting, Western, pubmed-meshheading:16170365-Cadherins, pubmed-meshheading:16170365-Cell Adhesion, pubmed-meshheading:16170365-Cell Line, Tumor, pubmed-meshheading:16170365-Cell Movement, pubmed-meshheading:16170365-Cytoskeletal Proteins, pubmed-meshheading:16170365-Disease Progression, pubmed-meshheading:16170365-Down-Regulation, pubmed-meshheading:16170365-Epithelium, pubmed-meshheading:16170365-Gene Expression Regulation, Neoplastic, pubmed-meshheading:16170365-Humans, pubmed-meshheading:16170365-Immunohistochemistry, pubmed-meshheading:16170365-Matrix Metalloproteinase 14, pubmed-meshheading:16170365-Matrix Metalloproteinase 2, pubmed-meshheading:16170365-Matrix Metalloproteinases, pubmed-meshheading:16170365-Matrix Metalloproteinases, Membrane-Associated, pubmed-meshheading:16170365-Melanoma, pubmed-meshheading:16170365-Microscopy, Fluorescence, pubmed-meshheading:16170365-Neoplasm Invasiveness, pubmed-meshheading:16170365-Proteins, pubmed-meshheading:16170365-RNA, pubmed-meshheading:16170365-RNA, Messenger, pubmed-meshheading:16170365-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:16170365-Tissue Distribution, pubmed-meshheading:16170365-Transcription, Genetic, pubmed-meshheading:16170365-Transfection
pubmed:year
2006
pubmed:articleTitle
Expression of Hugl-1 is strongly reduced in malignant melanoma.
pubmed:affiliation
Institute of Pathology, University Regensburg, Regensburg, Germany.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't